filmov
tv
Improving the Prognosis for Patients With mCRPC
Показать описание
Daniel J. George, MD, highlights emerging trials such as PEACE III that further explore the use of radium-223 in prostate cancer and reinforce important variables in managing patients with metastatic castration-resistant prostate cancer (mCRPC).
0:04:56
0:01:02
0:03:03
0:03:11
0:18:19
0:01:23
0:04:11
0:24:14
0:18:59
0:01:00
0:01:52
0:00:31
0:02:14
0:00:59
0:13:38
0:00:50
0:03:56
0:00:42
0:04:54
0:00:16
0:06:07
0:00:49
0:05:26
0:00:15